These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 12494449)

  • 61. Insulin-like growth factor-1 signaling is responsible for cathepsin G-induced aggregation of breast cancer MCF-7 cells.
    Morimoto-Kamata R; Yui S
    Cancer Sci; 2017 Aug; 108(8):1574-1583. PubMed ID: 28544544
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Targeting highly expressed extracellular HSP90 in breast cancer stem cells inhibits tumor growth in vitro and in vivo.
    Stivarou T; Stellas D; Vartzi G; Thomaidou D; Patsavoudi E
    Cancer Biol Ther; 2016 Aug; 17(8):799-812. PubMed ID: 27259689
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Cross-Talk between Adiponectin and IGF-IR in Breast Cancer.
    Mauro L; Naimo GD; Ricchio E; Panno ML; Andò S
    Front Oncol; 2015; 5():157. PubMed ID: 26236690
    [TBL] [Abstract][Full Text] [Related]  

  • 64. IGF-1 Receptor and Adhesion Signaling: An Important Axis in Determining Cancer Cell Phenotype and Therapy Resistance.
    Cox OT; O'Shea S; Tresse E; Bustamante-Garrido M; Kiran-Deevi R; O'Connor R
    Front Endocrinol (Lausanne); 2015; 6():106. PubMed ID: 26191041
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A randomised non-comparative phase II trial of cixutumumab (IMC-A12) or ramucirumab (IMC-1121B) plus mitoxantrone and prednisone in men with metastatic docetaxel-pretreated castration-resistant prostate cancer.
    Hussain M; Rathkopf D; Liu G; Armstrong A; Kelly WK; Ferrari A; Hainsworth J; Joshi A; Hozak RR; Yang L; Schwartz JD; Higano CS
    Eur J Cancer; 2015 Sep; 51(13):1714-24. PubMed ID: 26082390
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The role of the insulin‑like growth factor (IGF) axis in osteogenic and odontogenic differentiation.
    Al-Kharobi H; El-Gendy R; Devine DA; Beattie J
    Cell Mol Life Sci; 2014 Apr; 71(8):1469-76. PubMed ID: 24232361
    [TBL] [Abstract][Full Text] [Related]  

  • 67. IGF-1 receptor and IGF binding protein-3 might predict prognosis of patients with resectable pancreatic cancer.
    Hirakawa T; Yashiro M; Murata A; Hirata K; Kimura K; Amano R; Yamada N; Nakata B; Hirakawa K
    BMC Cancer; 2013 Aug; 13():392. PubMed ID: 23962053
    [TBL] [Abstract][Full Text] [Related]  

  • 68. MicroRNA-100 regulates IGF1-receptor expression in metastatic pancreatic cancer cells.
    Huang JS; Egger ME; Grizzle WE; McNally LR
    Biotech Histochem; 2013 Oct; 88(7):397-402. PubMed ID: 23373509
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cellular distribution of the IGF-1R in corneal epithelial cells.
    Robertson DM; Zhu M; Wu YC
    Exp Eye Res; 2012 Jan; 94(1):179-86. PubMed ID: 22193032
    [TBL] [Abstract][Full Text] [Related]  

  • 70. LIP expression is regulated by IGF-1R signaling and participates in suppression of anoikis.
    Li H; Baldwin BR; Zahnow CA
    Mol Cancer; 2011 Aug; 10():100. PubMed ID: 21854628
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Will targeting insulin growth factor help us or hurt us?: An oncologist's perspective.
    Kamrava M; Gius D; Casagrande G; Kohn E
    Ageing Res Rev; 2011 Jan; 10(1):62-70. PubMed ID: 19896561
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Heme-binding protein HRG-1 is induced by insulin-like growth factor I and associates with the vacuolar H+-ATPase to control endosomal pH and receptor trafficking.
    O'Callaghan KM; Ayllon V; O'Keeffe J; Wang Y; Cox OT; Loughran G; Forgac M; O'Connor R
    J Biol Chem; 2010 Jan; 285(1):381-91. PubMed ID: 19875448
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The insulin-like growth factor (IGF) receptor type 1 (IGF1R) as an essential component of the signalling network regulating neurogenesis.
    Annenkov A
    Mol Neurobiol; 2009 Dec; 40(3):195-215. PubMed ID: 19714501
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Clinical significance of insulin-like growth factor-1 receptor expression in stage I non-small-cell lung cancer: immunohistochemical analysis.
    Lee CY; Jeon JH; Kim HJ; Shin DH; Roh TW; Ahn CM; Chang YS
    Korean J Intern Med; 2008 Sep; 23(3):116-20. PubMed ID: 18787363
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Regulation of cyclooxygenase-2 (COX-2) expression in human pancreatic carcinoma cells by the insulin-like growth factor-I receptor (IGF-IR) system.
    Stoeltzing O; Liu W; Fan F; Wagner C; Stengel K; Somcio RJ; Reinmuth N; Parikh AA; Hicklin DJ; Ellis LM
    Cancer Lett; 2007 Dec; 258(2):291-300. PubMed ID: 17950526
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Expression of nuclear insulin receptor substrate 1 in breast cancer.
    Sisci D; Morelli C; Garofalo C; Romeo F; Morabito L; Casaburi F; Middea E; Cascio S; Brunelli E; Andò S; Surmacz E
    J Clin Pathol; 2007 Jun; 60(6):633-41. PubMed ID: 16882697
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The insulin-like growth factor I receptor is required for Akt activation and suppression of anoikis in cells transformed by the ETV6-NTRK3 chimeric tyrosine kinase.
    Martin MJ; Melnyk N; Pollard M; Bowden M; Leong H; Podor TJ; Gleave M; Sorensen PH
    Mol Cell Biol; 2006 Mar; 26(5):1754-69. PubMed ID: 16478996
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Role of insulin in the progression of ovarian sex cord stromal tumors in rats.
    Dragonas C; Mueller A; Maltaris T; Kraemer P; Dimmler A; Jaeger W; Beckmann MW; Dittrich R
    J Cancer Res Clin Oncol; 2005 Nov; 131(11):751-7. PubMed ID: 16136354
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Stat3 is required for full neoplastic transformation by the Simian Virus 40 large tumor antigen.
    Vultur A; Arulanandam R; Turkson J; Niu G; Jove R; Raptis L
    Mol Biol Cell; 2005 Aug; 16(8):3832-46. PubMed ID: 15917293
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Gene expression profiling of epithelial ovarian tumours correlated with malignant potential.
    Warrenfeltz S; Pavlik S; Datta S; Kraemer ET; Benigno B; McDonald JF
    Mol Cancer; 2004 Oct; 3():27. PubMed ID: 15471544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.